20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          SATB1 plays an important role in human malignant progression, inducing cancer cell proliferation and metastasis by regulating downstream gene expressions. However, little is known about the underlying mechanisms in which SATB1 promotes pancreatic cancer tumorigenesis.

          Aims

          To investigate SATB1 expression levels and its biological functions in promoting pancreatic cancer growth and invasion.

          Methods

          SATB1 expression levels were detected in seven human pancreatic cancer cell lines and 16 pairs of normal pancreatic/pancreatic cancer tissues using RT-PCR and western blot. SW1990 or Capan-1 cells stably knockdown (shRNA) or transiently knockdown (siRNA) SATB1 cells, and PANC-1 stably overexpressing SATB1 cells were investigated with MTT, EdU assay, flow cytometry, and transwell invasion assay for cell proliferation and invasion activity. The binding of SATB1 to MYC promoter region was examined using reporter assay. Expression of SATB1 in 68 pancreatic cancer samples was studied by immunohistochemical staining and scoring.

          Results

          SATB1 was overexpressed in pancreatic cancer tissues samples, showing strong correlation with pancreatic cancer invasion depth and tumor staging. SATB1 induced MYC mRNA and protein expression; promoted pancreatic cancer cell growth; increased cell population in S phase; and enhanced pancreatic cancer cell invasion in vitro. On the other hand, SATB1 knockdown showed opposite effects. Furthermore, MYC blocking in SATB1-overexpressing cells attenuated the promotion of pancreatic cancer cell growth and invasion. Our data also indicated that SATB1 bound to specific promoter region of MYC.

          Conclusions

          SATB1 is overexpressed in pancreatic cancer, promoting cancer cell proliferation and invasion through the activation of MYC.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer Statistics, 2008

          Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,437,180 new cancer cases and 565,650 deaths from cancer are projected to occur in the United States in 2008. Notable trends in cancer incidence and mortality include stabilization of incidence rates for all cancer sites combined in men from 1995 through 2004 and in women from 1999 through 2004 and a continued decrease in the cancer death rate since 1990 in men and since 1991 in women. Overall cancer death rates in 2004 compared with 1990 in men and 1991 in women decreased by 18.4% and 10.5%, respectively, resulting in the avoidance of over a half million deaths from cancer during this time interval. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. Although much progress has been made in reducing mortality rates, stabilizing incidence rates, and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reflecting on 25 years with MYC.

            Just over 25 years ago, MYC, the human homologue of a retroviral oncogene, was identified. Since that time, MYC research has been intense and the advances impressive. On reflection, it is astonishing how each incremental insight into MYC regulation and function has also had an impact on numerous biological disciplines, including our understanding of molecular oncogenesis in general. Here we chronicle the major advances in our understanding of MYC biology, and peer into the future of MYC research.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

                Bookmark

                Author and article information

                Contributors
                czjssry@gmail.com
                lizengliang123@126.com
                liwei10@suda.edu.cn
                zangy_0316@yahoo.com.cn
                zhuyijssry@126.com
                miaoyi@njmu.edu.cn
                86-13809031818 , xzkjssry@gmail.com , xuzekuan@njmu.edu.cn
                Journal
                Dig Dis Sci
                Dig. Dis. Sci
                Digestive Diseases and Sciences
                Springer US (New York )
                0163-2116
                1573-2568
                25 June 2015
                25 June 2015
                2015
                : 60
                : 11
                : 3304-3317
                Affiliations
                [ ]Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029 People’s Republic of China
                [ ]Institute of Tumor Biology, Jiangsu Province Academy of Clinical Medicine, Nanjing, People’s Republic of China
                [ ]Department of Gastrointestinal Surgery, Huai’an First People’s Hospital, Nanjing Medical University, 6 Beijing Road West, Huai’an, 223300 People’s Republic of China
                [ ]Department of General Surgery, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, People’s Republic of China
                [ ]Department of Oncology, The First Affiliated Hospital of Soochow University, No. 1, Shizi Street, Suzhou City, 215006 People’s Republic of China
                [ ]Department of General Surgery, Changshu No. 1 People’s Hospital, 1 Shuyuan Street, Changshu, 215500 People’s Republic of China
                Article
                3759
                10.1007/s10620-015-3759-9
                4621700
                26108419
                e4c20abc-eac7-4591-850e-46f4284a3a17
                © The Author(s) 2015

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 12 March 2015
                : 10 June 2015
                Categories
                Original Article
                Custom metadata
                © Springer Science+Business Media New York 2015

                Gastroenterology & Hepatology
                special at-rich binding protein 1,pancreatic carcinoma,cell cycle,myelocytomatosis viral oncogene

                Comments

                Comment on this article